Ardelyx Completes Enrollment in Phase 3 Ibsrela Trial
Ardelyx said it has fully enrolled patients in its Phase 3 Ibsrela trial for chronic idiopathic constipation.
Ardelyx said it has fully enrolled patients in its Phase 3 Ibsrela trial for chronic idiopathic constipation.